CIK: 1376260 - Address: 260 Sheridan Avenue, Suite 400, Palo Alto, CA 94306
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret115-3-4-61-41-55-18
S%wins100808020608070

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

10/7/21 18:24
10/5/21
CRTXCortexyme, Inc.DEHealthBioPrdBiological Products, (No DiagLowe Christopher P.CAOCOO,CFOS.d-48998.500-5-860D
8/18/21 17:25
8/16/21
CRTXCortexyme, Inc.DEHealthBioPrdBiological Products, (No DiagLowe Christopher P.CAOCOO,CFOS.d-2,09795.310-22-2760D
6/30/21 17:46
6/28/21
CRTXCortexyme, Inc.DEHealthBioPrdBiological Products, (No DiagLowe Christopher P.CAOCOO,CFOS.d-1,08354.150-20-4030D
2/3/12 16:01
2/1/12
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLowe Christopher P.CAOC.F.O.,CS-1157.660-15-3331D761523211794-1-5-23-80-90-94
11/4/11 20:24
11/3/11
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLowe Christopher P.CAOCFO,CBOS-1036.880-15-2546D30-2104118-19-5-2-420-73-87
10/27/11 19:48
10/25/11
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLowe Christopher P.CAOCFO,CBOS-337.070-5-761I150-105143274-8-11-273-82-90
8/4/11 20:08
8/2/11
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLowe Christopher P.CAOCFO,CBOS.m-1376.990-20-2656M21520-13-13-14-12-1-14-13224-76
2/14/11 19:18
2/11/11
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsLowe Christopher P.CAOVP of AdS00.000-81-5177I-3-24-94-31101135621472

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact